Abstract
Reliable and sensitive detection of metastasis is critical to establishing accurate staging and to designing effective therapies for patients with colon carcinoma. Preoperative techniques, such as computed tomography (CT) scan and magnetic resonance imaging (MRI), have increased the ability of the surgeon to detect dissemination of disease. During surgery, the surgeon relies mostly on direct palpation and inspection in order to identify tumor and assess the completeness of resection.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Martin EW, Carey LC. Second look surgery for colorectal cancer. Ann Surg 1991; 214: 321–327.
Cohen AM, Martin EW Jr, Lavery I, Daly J, Sardi A, Aitken D, Bland K, Mojzisik C, Hinkle G. Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. Arch Surg 1991;126:349–352.
Arnold MW, Schneebaum S, Berens A, Petty L, Mojzisik C, Hinkle G, Martin EW Jr. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second generation monoclonal antibody. Ann Surg 1992;216:627–632.
Arnold MW, Schneebaum S, Petty LR, Martin EW Jr. Carcinoembryonic antigen-directed second-look surgery. In Wanebo HJ, ed. Colorectal Cancer. St. Louis, MO: Mosby, 1993, pp 389–404.
Cohen AM, Shank B, Friedmann MA. Colorectal cancer. In DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer Principles and Practices of Oncology. Philadelphia: JB Lippincott, 1989, pp 949–951.
Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, Oliff L, Schlag P. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to survey for peritoneal carcinomatosis from gastrointestinal cancer: Pharmacological studies. Cancer Res 1990;50:5790–5794.
Hojo K. Surgery for far-advanced colorectal cancer: Extension of surgical indications and its results. Nippon Geka Gakkai Zasshi 1989;90:1428–1431.
Sugarbaker PH, Land D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 1990;65:1495–1501.
Cavaliere R, Ciocatto B, Giovanella B, Heidelberger C, Johnson RO, Margottini M, Mondovi B, Morrica G, Rossi-Fanelli A. Selective heat sensitivity of cancer cells. Cancer 1967;20:1351–1360.
Teicher BA, KowaL CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41: 1096–1099.
Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256–260.
FujiMoto S, Shersha RD, Kokubun M, Ohta M, Takahshi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N, Takamizawa H. Intraoperative hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36–40.
Schneebaum S, Lange MK, Arnold MW, Ralston J, Dumond DA. Intraperitoneal hyperthermic perfusion for recurrent colorectal cancer — feasibility study. Reg Cancer Treat 1992;4:277–281.
Schneebaum S, Staubus AE, Asif M, Arnold M, Martin EW Jr. Pharmacokinetics of mitomycin C during intraperitoneal hyperthermic perfusion. Proc Am Assoc Cancer Rex 1992;33:530.
Schneebaum S, Arnold M, Staubus AE, Young D, Dumond D, Martin EW, Jr. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. 46th Annual Cancer Symposium, the Society of Surgical Oncology, Los Angeles, CA. Proceedings of the Society of Surgical Oncology, A:259.
Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986;46:3118–3124.
Colcher D, Horan Hand P, Nuri M, Schlom J. A spectrum of monoclonal antibodies with mammary tumor cells. Proc Natl Acad Sci USA 1981;78:3199–3203.
Cohen CJ. Surgical considerations in ovarian cancer. Semin Oncol 1985;12(Suppl 4):53–56.
Markman M. Intraperitoneal chemotherapy. In Perry MC, ed. The Chemotherapy Source Book. Baltimore, MD: Williams & Wilkins 1992, pp 226–231.
Sugarbaker PH, Cundiffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Cancer Semin Oncol 1989;16:83–97.
Sugarbaker PH. Curative tratment of peritoneal carcinomatosis from grade I mucinous adenocarcinoma. Surg Rounds 1988;11:45–63.
Fujimoto S, Shersha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Takahashi M, Kitsukawa Y, Mizutani M, Chikenji T, Okui K. Clinical outcome of combined therapy of intraoperative hyperthermochemotherapy and surgery for patients with peritoneal recurrence from gastric cancer. Reg Cancer Treat 1990;3:181–184.
Fujimoto S, Shersha RD, Kokubun M, Kobayashi K, Kiuchi S, Takahashi M, Konno C, Ohta M, Koike S, Kitsukawa Y, Mizutani M, Okui K. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer 1989;64:157–160.
Smith GV, McMillan R, Stribling J. Intraperitoneal approach to regional hyperthermia — possible anticancer applications. World J Surg 1983;7:732–737.
Lele PP. Thresholds and mechanisms of ultrasonic damage to organized animal tissues. In Hazzard DG, Litz ML, eds. Symposium on Biologic Effects and Characterization of Ultrasound Sources. Proceedings of a Conference in Rockville, Maryland, June 2–3, 1977. HEW Publications (FDA) 8048, 1978, p 224.
Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF. Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 1975;140: 339–368.
Fujimoto S, Kokubun M, Shrestha RD, Kobayashi K, Kiuchi S, Konno C, Tekahashi M, et al. Prevention of scald injury on the peritoneo-serosal surface in advanced gastric cancer patients treated with intraperitoneal hyperthermic perfusion. Int J Hyperthermia 1991;7: 543–550.
Fumagalli U, Trabucchi E, Soligo M, Rosati R, Rebuffat C, Tonelli C, Montorsi M. Effects of intraperitoneal chemotherapy on anastomotic healing in the rat. J Surg Res 1991;50:82–87.
Engelmann U, Sonntag W, Jacobi GH. Influence of perioperative cisplatinum on breaking strength of bowel anastomoses in rats. In Metzger U, Largiader F, Senn JH, eds. Perioperative Chemotherapy. Recent Results Cancer Res 1985;98:35.
Los G, Smals OAF, van Vugt MJH, van der Vlist M, den Engelse L, McVie JG, Pinedo HM. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res 1992;52:1252–1258.
Steis RG, Urba WJ, Van der Molen LA, Bookman MA, Smith II JW, Clark RL, Edward DC, et al. Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity. J Clin Oncol 1990;8:1618–1629.
Song CW, Lin J-C, Lyons JC. Antitumor effect of interleukin 1-alpha in combination with hyperthermia. Cancer Res 1993;53:324–328.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Schneebaum, S., Arnold, M.W., Staubus, A.E., Martin, E.W. (1996). Peritoneal carcinomatosis and radioimmunoguided surgery. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Principles of Management. Cancer Treatment and Research, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1247-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1247-5_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8531-1
Online ISBN: 978-1-4613-1247-5
eBook Packages: Springer Book Archive